In this presentation, Karla Thornton, MD, MPH, describes epidemiology of HCV in pregnancy, reviews the importance of testing for HCV in pregnancy, and describe early data in HCV treatment trial… […]
Keyword: hcv treatment
Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
In this presentation, Jessica Orizu, PharmD Candidate, will review the use of direct-acting antivirals (DAAs) in patients with swallowing difficulties, focusing on the use of sofosbuvir/velpatasvir (Epclusa) and glecaprevir/pibrentasvir (Mavyret).… […]
Read More… from Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
Common HCV DAA Drug Interactions | September 25, 2024
In this presentation, Dr. Brad Moran describes the interaction potential between DAA therapies and common medications. […]
Read More… from Common HCV DAA Drug Interactions | September 25, 2024
Hepatitis C Screening and Treatment | September 11, 2024
In this presentation, Brian McMahon, MD and Lisa Townshend-Bulson, RN, MSN, FNP-C from the ANTHC Liver Disease & Hepatitis Program discuss hepatitis C screening and treatment. They cover why screening… […]
Read More… from Hepatitis C Screening and Treatment | September 11, 2024
HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
HCV Screening, Management and Treatment Guidelines | March 13, 2024
In this training, Dr. Paulina Deming, Dr. Karla Thornton, and Dr. Richard Manch discuss treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment,… […]
Read More… from HCV Screening, Management and Treatment Guidelines | March 13, 2024
Common HCV DAA Drug Interactions | September 27, 2023
In this presentation, Dr. Paulina Deming describes the interaction potential between DAA therapies and common medications, and identifies when DAA therapies and diabetic medications are most likely to result in… […]
Read More… from Common HCV DAA Drug Interactions | September 27, 2023
HCV Treatment Monitoring: Keeping it Simple | August 23, 2023
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | August 23, 2023
HCV Management and Treatment Guidelines | December 5, 2023
In this training, Dr. Jorge Mera discusses treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring. […]
Read More… from HCV Management and Treatment Guidelines | December 5, 2023
HCV Screening, Management and Treatment Guidelines | October 6, 2023
In this training, Dr. Jorge Mera discusses treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring. […]
Read More… from HCV Screening, Management and Treatment Guidelines | October 6, 2023